DE602005022431D1 - Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit - Google Patents

Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit

Info

Publication number
DE602005022431D1
DE602005022431D1 DE602005022431T DE602005022431T DE602005022431D1 DE 602005022431 D1 DE602005022431 D1 DE 602005022431D1 DE 602005022431 T DE602005022431 T DE 602005022431T DE 602005022431 T DE602005022431 T DE 602005022431T DE 602005022431 D1 DE602005022431 D1 DE 602005022431D1
Authority
DE
Germany
Prior art keywords
compositions
reducing
methods
preventing grease
lubricity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022431T
Other languages
English (en)
Inventor
Yuanlong Pan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of DE602005022431D1 publication Critical patent/DE602005022431D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
DE602005022431T 2004-03-17 2005-03-17 Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit Active DE602005022431D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55387104P 2004-03-17 2004-03-17
PCT/EP2005/002865 WO2005089567A1 (en) 2004-03-17 2005-03-17 Compositions and methods for reducing or preventing obesity

Publications (1)

Publication Number Publication Date
DE602005022431D1 true DE602005022431D1 (de) 2010-09-02

Family

ID=34972657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022431T Active DE602005022431D1 (de) 2004-03-17 2005-03-17 Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit

Country Status (12)

Country Link
US (2) US8193240B2 (de)
EP (2) EP1750523B1 (de)
JP (2) JP5283902B2 (de)
CN (1) CN1933739A (de)
AU (1) AU2005224017B2 (de)
BR (1) BRPI0508936A (de)
CA (1) CA2559974C (de)
DE (1) DE602005022431D1 (de)
ES (2) ES2346234T3 (de)
RU (1) RU2366274C2 (de)
WO (1) WO2005089567A1 (de)
ZA (1) ZA200608626B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
BRPI0615211A2 (pt) 2005-08-17 2013-01-15 Hills Pet Nutrition Inc composiÇço, mÉtodo para evitar ou tratar doenÇa renal ou para a melhora da funÇço renal, kit, e, meio para comunicar informaÇço sobre ou instruÇÕes para a mistura e administraÇço de um ou mais das composiÇÕes, componentes de composiÇço, composiÇÕes alimentÍcias, ingredientes alimentÍcios e medicamentos renais e para uso dos dispositivos de diagnàstico renal
JP2009514824A (ja) * 2005-11-02 2009-04-09 ネステク ソシエテ アノニム 雄の哺乳動物における体脂肪の蓄積を低減するためのイソフラボン組成物及びその使用方法
CN101389328B (zh) * 2006-02-28 2013-04-24 雀巢技术公司 诱导骨生长和抑制骨流失的组合物和方法
EP1875908A1 (de) * 2006-07-05 2008-01-09 Johannes Huber Verwendung von Chrysin
JP2009545605A (ja) * 2006-08-02 2009-12-24 ユニバーシティ オブ サザン カリフォルニア フィトエストロゲン製剤およびその使用
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
CN102919738B (zh) 2007-06-13 2016-05-11 大塚制药株式会社 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品
CN101326966B (zh) * 2008-07-22 2010-09-08 浙江大学 一种改进大黄鱼品质的饲料添加剂
AU2009282482B2 (en) * 2008-08-15 2015-11-26 Société des Produits Nestlé S.A. Methods for enhancing energy metabolism
CN104222518A (zh) * 2008-12-30 2014-12-24 希尔氏宠物营养品公司 用于治疗和预防伴侣动物的与体重相关疾病的组合物和方法
CN102271676B (zh) 2008-12-30 2014-07-23 希尔氏宠物营养品公司 硫辛酸在治疗或预防陪伴动物的退行性关节病症、骨关节炎、软骨损伤，以及相关障碍中的应用
WO2010100653A2 (en) * 2009-02-02 2010-09-10 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
JP5470648B2 (ja) * 2009-03-02 2014-04-16 学校法人加計学園 ペルオキシゾーム増殖剤応答性受容体β／δ活性化剤
KR101119877B1 (ko) 2009-03-03 2012-02-28 (주)에이치케이바이오텍 지방감소를 위한 피부도포용 조성물 및 이것의 제조방법
ES2688447T3 (es) * 2009-10-09 2018-11-02 Nestec S.A. Métodos para prevenir o tratar la sarcopenia y la atrofia muscular en animales
EP2506764B1 (de) * 2010-01-06 2017-03-15 Hill's Pet Nutrition, Inc. Verfahren zur verwaltung von gewichtsstörungen bei tieren
EP2654451B1 (de) * 2010-12-20 2016-04-13 Hill's Pet Nutrition, Inc. Tiernahrungszusammensetzungen zur herbeiführung einer sättigungsreaktion
EP2654777A4 (de) * 2010-12-21 2014-07-09 Nestec Sa Verfahren und zusammensetzungen zur verwaltung des blutzuckers bei tieren
WO2012141876A1 (en) * 2011-04-15 2012-10-18 Nestec S.A. Methods for regulating sirtuin gene expression
RU2607109C2 (ru) * 2011-04-20 2017-01-10 Нестек С.А. Способы и композиции, пригодные для предотвращения и лечения гиперлептинемии
WO2016004363A2 (en) * 2014-07-03 2016-01-07 NAN Global, LLC Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes
EP3223634A1 (de) * 2014-11-25 2017-10-04 Nestec S.A. Verfahren und zusammensetzungen zur aufrechterhaltung einer schlanken körperform und zur förderung des fettabbaus während eines gewichtsverlustes
CA3029291A1 (en) * 2016-12-15 2018-06-21 Rondo P. Middleton Compositions and methods for small canines
US10842809B2 (en) 2016-12-16 2020-11-24 Hills Pet Nutrition, Inc. Pet food compositions
CN106804483B (zh) * 2016-12-30 2020-11-10 浙江海洋大学 一种提高大黄鱼体石榴酸的方法
CN108260731A (zh) * 2017-01-03 2018-07-10 江苏益力达生物科技有限公司 一种控制宠物犬猫体重的营养膏
CN106901042A (zh) * 2017-04-27 2017-06-30 上海美嘉饲料有限公司 一种提高种公猪精子活力的饲料添加剂
CN108354080A (zh) * 2018-05-14 2018-08-03 江苏奈乐宠物食品科技有限公司 一种肥胖期专用减肥犬粮的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
EP0628258A4 (de) 1992-12-25 1995-04-19 Kanegafuchi Chemical Ind Körnige farbstoffe und säugungsnahrungsmittel das diese enthält.
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
SE506191C2 (sv) 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
JPH10175866A (ja) 1996-12-18 1998-06-30 Showa Denko Kk 動物用ストレス反応緩和剤及びストレス反応の緩和方法
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
ID28173A (id) * 1998-06-26 2001-05-10 Iams Company Proses dan produk untuk mengurangi berat badan anjing yang kegemukan
US20010041187A1 (en) * 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
ATE549939T1 (de) 1999-02-24 2012-04-15 Iams Company Diätzusammensetzungen und verfahren
GB2355382A (en) * 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog
ITMI991894A1 (it) 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
WO2001074345A2 (en) * 2000-03-31 2001-10-11 Jonathan Ingram Isoflavones for treatment of obesity
KR20020060577A (ko) * 2000-07-07 2002-07-18 아키라 이가키 비만 억제제
JP2002080351A (ja) 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
US7045164B2 (en) * 2000-11-09 2006-05-16 Cargill, Incorporated Soybean processing
US6541613B2 (en) 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
GB0119052D0 (en) 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
US20030138547A1 (en) 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
EP1474129A1 (de) * 2002-02-15 2004-11-10 N.V. Nutricia Verwendung von genistein zur herstellung eines medikaments zur behandlung von osteoporose und obesität und zusammenstezungen enthaltend genistein mit vitamin d und k
JP2003286180A (ja) * 2002-03-28 2003-10-07 Fuji Oil Co Ltd 肥満抑制剤及びそれを含む食品
EP1388297A1 (de) * 2002-08-06 2004-02-11 Nestec S.A. Calcium-Aufnahme Verstärker
US20040151761A1 (en) 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
JP4152818B2 (ja) * 2003-02-06 2008-09-17 日清オイリオグループ株式会社 共役脂肪酸を有効成分とする高血圧予防剤およびその用途
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
CN101389328B (zh) * 2006-02-28 2013-04-24 雀巢技术公司 诱导骨生长和抑制骨流失的组合物和方法

Also Published As

Publication number Publication date
BRPI0508936A (pt) 2007-09-25
CN1933739A (zh) 2007-03-21
US8883192B2 (en) 2014-11-11
CA2559974A1 (en) 2005-09-29
JP5283902B2 (ja) 2013-09-04
US20120270814A1 (en) 2012-10-25
CA2559974C (en) 2012-08-14
EP1750523A1 (de) 2007-02-14
JP2012165746A (ja) 2012-09-06
US20050222050A1 (en) 2005-10-06
ES2346234T3 (es) 2010-10-13
JP2007529211A (ja) 2007-10-25
AU2005224017A1 (en) 2005-09-29
EP2208422A1 (de) 2010-07-21
EP2208422B1 (de) 2015-11-25
ZA200608626B (en) 2008-07-30
US8193240B2 (en) 2012-06-05
AU2005224017B2 (en) 2010-12-16
RU2366274C2 (ru) 2009-09-10
RU2006136420A (ru) 2008-04-27
EP1750523B1 (de) 2010-07-21
ES2559777T3 (es) 2016-02-15
WO2005089567A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
DE602005022431D1 (de) Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit
DE602004019833D1 (de) Zusammensetzungen zur Zinnlegierungselektroplattierung und Verfahren
ATE500824T1 (de) Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol
DE502005003560D1 (de) Verfahren zur alkoxylierung von alkyl-und/oder alkenylpolyglykosiden
DE602006004968D1 (de) Verfahren und anlage zur umwandlung von chromhaltigem gefährlichem abfall in ungefählriche abfälle
DE602005025745D1 (de) Markierte abstützmittel und verwandte verfahren
DE602006005208D1 (de) Tonerzusammensetzung und Verfahren
DE602004015337D1 (de) Verdichter mit rückführung und verfahren
DE602006021318D1 (de) Insektizidzusammensetzungen und verfahren zur hersn
ZA200805513B (en) Process for making and composition of superior lubricant or lubricant blendstock
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
SI2277976T1 (sl) Sestavki, ki vsebujejo HFC-1234ZE in mazivo
ATE398455T1 (de) Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
ATE469957T1 (de) Verfahren zur herstellung von ölzusammensetzungen
DE602005019034D1 (de) System und verfahren zur adaptiven wegplanung
EP1795581A4 (de) Acrylpolymer enthaltendes schmieröladditiv und schmierölzusammensetzungen
IL180907A0 (en) Risedronate compositions and their methods of use
DE602004010329D1 (de) Fett- oder Ölzusammensetzung
DE602006015182D1 (de) Zusammensetzung und verfahren zur kontrolle von insekten
HK1121952A1 (en) Methods and compositions for treating conditions
DE602006001891D1 (de) Verfahren zur Herstellung von Fett oder Öl
DE602007001706D1 (de) Tonerzusammensetzung und Verfahren
ATE540755T1 (de) Verwendung von katalysatorzusammensetzungen und verfahren zur oxychlorierung
EP1786428A4 (de) Pde5-hemmer-zusammensetzungen und verfahren zur behandlung von herzerkrankungen
IL220806A0 (en) Method and compositions for enhancing vascular access